Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

Ítems similars

• Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation
  per: Tomac, Gordana, et al.
  Publicat: (2018)
• Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation
  per: Aung, Fleur M., et al.
  Publicat: (2013)
• Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation
  per: Yang, X., et al.
  Publicat: (2014)
• Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia
  per: Mehmet Sezgin Pepeler, et al.
  Publicat: (2024-12-01)
• Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia
  per: Aung, Fleur M., et al.
  Publicat: (2016)